Recent Advances of Gold Compounds in Anticancer Immunity

被引:68
作者
Yue, Shuang [1 ]
Luo, Miao [1 ]
Liu, Huiguo [1 ]
Wei, Shuang [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Resp & Crit Care Med, Wuhan, Peoples R China
基金
中国国家自然科学基金;
关键词
gold compounds; innate immunity; adaptive immunity; immunogenic cell death; immune checkpoints;
D O I
10.3389/fchem.2020.00543
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In recent years, gold compounds have gained more and more attentions in the design of new metal anticancer drugs. Numerous researches have reported that gold compounds, in addition to their widely studied cytotoxic antitumor effects, also reverse tumor immune escape and directly facilitate the functions of immune cells, leading to enhanced anticancer effects. This review mainly summarizes our current understandings of antitumor effects of gold drugs and their relationships with various aspects of antitumor immunity, including innate immunity, adaptive immunity, immunogenic cell death, and immune checkpoints, as well as their roles in adverse effects. Some recent examples of anticancer gold compounds are highlighted. The property of gold compounds is expected to combine with anticancer immunotherapy, such as immune checkpoint inhibitors, to develop new anticancer therapeutic strategies.
引用
收藏
页数:14
相关论文
共 121 条
[61]   Molecular recognition of metal complexes by DNA:: A comparative study of the interactions of the parent complexes [PtCl(TERPY)]Cl and [AuCl(TERPY)]Cl2 with double stranded DNA [J].
Messori, L ;
Marcon, G ;
Innocenti, A ;
Gallori, E ;
Franchi, M ;
Orioli, P .
BIOINORGANIC CHEMISTRY AND APPLICATIONS, 2005, 3 (3-4) :239-253
[62]   Recent advances in gold-NHC complexes with biological properties [J].
Mora, Malka ;
Concepcion Gimeno, M. ;
Visbal, Renso .
CHEMICAL SOCIETY REVIEWS, 2019, 48 (02) :447-462
[63]   The immune system and cancer evasion strategies: therapeutic concepts [J].
Muenst, S. ;
Laubli, H. ;
Soysal, S. D. ;
Zippelius, A. ;
Tzankov, A. ;
Hoeller, S. .
JOURNAL OF INTERNAL MEDICINE, 2016, 279 (06) :541-562
[64]   Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines [J].
Murray, Peter J. ;
Allen, Judith E. ;
Biswas, Subhra K. ;
Fisher, Edward A. ;
Gilroy, Derek W. ;
Goerdt, Sergij ;
Gordon, Siamon ;
Hamilton, John A. ;
Ivashkiv, Lionel B. ;
Lawrence, Toby ;
Locati, Massimo ;
Mantovani, Alberto ;
Martinez, Fernando O. ;
Mege, Jean-Louis ;
Mosser, David M. ;
Natoli, Gioacchino ;
Saeij, Jeroen P. ;
Schultze, Joachim L. ;
Shirey, Kari Ann ;
Sica, Antonio ;
Suttles, Jill ;
Udalova, Irina ;
van Ginderachter, Jo A. ;
Vogel, Stefanie N. ;
Wynn, Thomas A. .
IMMUNITY, 2014, 41 (01) :14-20
[65]   The gold compound auranofin induces apoptosis of human multiple myeloma cells through both down-regulation of STAT3 and inhibition of NF-κB activity [J].
Nakaya, Aya ;
Sagawa, Morihiko ;
Muto, Akihiro ;
Uchida, Hideo ;
Ikeda, Yasuo ;
Kizaki, Masahiro .
LEUKEMIA RESEARCH, 2011, 35 (02) :243-249
[66]   Gold Complexes for Therapeutic Purposes: an Updated Patent Review (2010-2015) [J].
Nardon, Chiara ;
Pettenuzzo, Nicolo ;
Fregona, Dolores .
CURRENT MEDICINAL CHEMISTRY, 2016, 23 (29) :3374-3403
[67]   Gold Nanoparticles as a Vaccine Platform: Influence of Size and Shape on Immunological Responses in Vitro and in Vivo [J].
Niikura, Kenichi ;
Matsunaga, Tatsuya ;
Suzuki, Tadaki ;
Kobayashi, Shintaro ;
Yamaguchi, Hiroki ;
Orba, Yasuko ;
Kawaguchi, Akira ;
Hasegawa, Hideki ;
Kajino, Kiichi ;
Ninomiya, Takafumi ;
Ijiro, Kuniharu ;
Sawa, Hirofumi .
ACS NANO, 2013, 7 (05) :3926-3938
[68]   Tumor-Associated Macrophages: From Mechanisms to Therapy [J].
Noy, Roy ;
Pollard, Jeffrey W. .
IMMUNITY, 2014, 41 (01) :49-61
[69]   Increased expression of CEA and MHC class I in colorectal cancer cell lines exposed to chemotherapy drugs [J].
Ohtsukasa, S ;
Okabe, S ;
Yamashita, H ;
Iwai, T ;
Sugihara, K .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2003, 129 (12) :719-726
[70]   Potential Anticancer Activity of Auranofin [J].
Onodera, Takefumi ;
Momose, Isao ;
Kawada, Manabu .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2019, 67 (03) :186-191